High sensitivity scanning of colorectal tumors and matched plasma DNA for mutations in APC, TP53, K-RAS, and BRAF genes with a novel DHPLC fluorescence detection platform

Annals of the New York Academy of Sciences
S L LillebergK Culver

Abstract

Tumor-associated DNA has been detected in plasma of colorectal cancer (CRC) patients using various techniques but with limited gene or mutation coverage. We report a highly sensitive scanning methodology for mutational assessment of the APC and TP53 genes, which typically pose an analytical challenge because of their significant genotypic heterogeneity as well as specific mutational scoring assays for K-RAS and BRAF. Plasma DNA isolated from 20 CRC patients were scanned for mutations in these targets without knowledge of the molecular or pathological analyses of the matched primary tumors. We chose mutation scanning technology and these molecular targets to provide a comprehensive screen for somatic mutations known to be associated with sporadic CRC. Mutations were identified with a novel denaturing high-performance liquid chromatography (DHPLC) platform that uses post-separation fluorescence technology to enable the detection of variants that represent <0.1% of the total analyzed DNA. Mutant allele specific amplification (MASA) followed by detection with the same platform was used to identify low-level target mutations (mutation scoring) in K-RAS codons 12, 13, and 61, and BRAF codon 599. Using this combined scanning and scori...Continue Reading

References

Jun 1, 1990·Cell·E R Fearon, B Vogelstein
Jul 3, 2002·Proceedings of the National Academy of Sciences of the United States of America·Gillian SmithC Roland Wolf

❮ Previous
Next ❯

Citations

Jul 29, 2005·The Journal of Molecular Diagnostics : JMD·Shuji OginoCharles S Fuchs
May 12, 2009·Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B·Deborah PackhamMegan P Hitchins
Mar 8, 2012·Molekuliarnaia biologiia·M A Emel'ianovaT V Nasedkina
Dec 25, 2012·Genes & Cancer·Rodney E ShackelfordDomenico Coppola
May 19, 2010·Biomarkers in Medicine·Barbara L Parsons, Fanxue Meng
Dec 15, 2015·Expert Review of Molecular Diagnostics·Kinga TóthBéla Molnár
Sep 1, 2010·Expert Opinion on Medical Diagnostics·Gernot KriegshäuserRobert Zeillinger
Sep 14, 2010·Gastroentérologie Clinique Et Biologique·T LecomteP Laurent-Puig
Jun 26, 2010·Clinica Chimica Acta; International Journal of Clinical Chemistry·Pamela PinzaniClaudio Orlando
Jul 17, 2007·Pathology, Research and Practice·Angela PoehlmannRegine Schneider-Stock
Mar 27, 2007·Advances in Enzyme Regulation·James A McCubreyAlberto M Martelli
Aug 9, 2018·Archives of Pathology & Laboratory Medicine·Jing LiVictoria H Brophy
Jun 4, 2005·Electrophoresis·Jens Bjørheim, Per Olaf Ekstrøm
Jun 11, 2005·Electrophoresis·David C HinselwoodPer O Ekstrøm
Jul 12, 2014·Oncology Letters·Nanqiu Peng, Xintai Zhao
Jul 15, 2017·The International Journal of Biological Markers·Fang TianYanfang Zhang
Nov 2, 2019·Biomarkers in Medicine·Xiaofeng DaiPeihua Lu
Sep 9, 2017·The International Journal of Biological Markers·Min TangJinbo Liu
Jun 10, 2011·Molecular Biology Reports·Marta Herreros-Villanueva, Gaurav Aggarwal
Jun 4, 2015·Expert Review of Anticancer Therapy·Yang LiSheng-Yong Wang
Aug 25, 2020·Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry·Ni ZengJuan Xiang
Sep 9, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lisa M CaroniaManisha H Shah

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenomatous Polyposis Coli

Adenomatous polyposis coli is a protein encoded by the APC gene and acts as a tumor suppressor. Discover the latest research on adenomatous polyposis coli here.